Brand : Celltrion

About Company

A leading force in the Korean pharmaceutical industry, Celltrion achieved what was thought impossible by launching the world’s first “antibody biosimilar” from a country with a relatively underdeveloped pharmaceutical sector. The company has pioneered numerous uncharted areas to stellar success, which it plans to follow up by continuing its growth as a global biopharmaceutical company with unique approaches to small molecule pharmaceuticals and new businesses such as the Ubiquitous-healthcare platform business.

Website :
Youtube :
Facebook :


Biosimilar, Small Molecules, New Medicines


Therapeutic Agents Against Cancer, Targeted therapy, Therapeutic Agents Against Autoimmune Diseases

Novel Therapeutic Agents
New Antibody Drugs, Fusion Technology, Vaccines

Novel Tech. Platform, New Business Models, Unmet Medical Needs, First Follower strategy


Bio pharmaceutical

Generic pharmaceutical

Test Kits



All trademarks, tradenames, logos, copyrighted material such as text and/or images herein are the property of their respective owners, where applicable.